Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD

Neovascular age-related macular degeneration (nAMD) is a leading cause of blindness in the aging population, with vascular endothelial growth factor (VEGF) playing a key role. Treatment with recombinant anti-VEGFs is the current standard of care; however, it is only effective for 1–2 months at a tim...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqball, Sharifah, Beck, Daniel K., Devarajan, Gayathri, Khoo, Cheen P., O’Connor, Deirdre M., Ellis, Scott, Guzman, Efrain, Mitrophanous, Kyriacos A., Lad, Yatish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448334/
https://www.ncbi.nlm.nih.gov/pubmed/37637380
http://dx.doi.org/10.1016/j.omtm.2023.07.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448334/
https://www.ncbi.nlm.nih.gov/pubmed/37637380
http://dx.doi.org/10.1016/j.omtm.2023.07.001

Ejemplares similares